[HTML][HTML] Biofabricated silver nanoparticles synergistically activate amphotericin B against mature biofilm forms of Candida albicans
SD Halbandge, SP Mortale… - The Open …, 2017 - benthamopen.com
Background: Biofilm formation by Candida albicans is a significant clinical challenge. Fungal
biofilms are resistant to most of the currently available antifungal agents. Amphotericin-B …
biofilms are resistant to most of the currently available antifungal agents. Amphotericin-B …
[PDF][PDF] The Open Nanomedicine Journal
BSNS Activate - pdfs.semanticscholar.org
Background: Biofilm formation by Candida albicans is a significant clinical challenge. Fungal
biofilms are resistant to most of the currently available antifungal agents. Amphotericin-B …
biofilms are resistant to most of the currently available antifungal agents. Amphotericin-B …
[PDF][PDF] The Open Nanomedicine Journal
BSNS Activate - scholar.archive.org
Background: Biofilm formation by Candida albicans is a significant clinical challenge. Fungal
biofilms are resistant to most of the currently available antifungal agents. Amphotericin-B …
biofilms are resistant to most of the currently available antifungal agents. Amphotericin-B …